Literature DB >> 29282854

Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy.

Peng Wang1, Lingmin Zhang1,2, Wenfu Zheng1, Liman Cong3, Zhaorong Guo3, Yangzhouyun Xie1, Le Wang1, Rongbing Tang1, Qiang Feng1, Yoh Hamada3, Kohsuke Gonda3, Zhijian Hu1, Xiaochun Wu1, Xingyu Jiang1,2,4.   

Abstract

CRISPR/Cas9 system is a powerful toolbox for gene editing. However, the low delivery efficiency is still a big hurdle impeding its applications. Herein, we report a strategy to deliver Cas9-sgPlk-1 plasmids (CP) by a multifunctional vehicle for tumor therapy. We condensed CPs on TAT peptide-modified Au nanoparticles (AuNPs/CP, ACP) via electrostatic interactions, and coated lipids (DOTAP, DOPE, cholesterol, PEG2000-DSPE) on the ACP to form lipid-encapsulated, AuNPs-condensed CP (LACP). LACP can enter tumor cells and release CP into the cytosol by laser-triggered thermo-effects of the AuNPs; the CP can enter nuclei by TAT guidance, enabling effective knock-outs of target gene (Plk-1) of tumor (melanoma) and inhibition of the tumor both in vitro and in vivo. This AuNPs-condensed, lipid-encapsulated, and laser-controlled delivery system provides a versatile method for high efficiency CRISPR/Cas9 delivery and targeted gene editing for treatment of a wide spectrum of diseases.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CRISPR/Cas9 delivery; gold nanoparticles; lipids; photothermal effect; tumor therapy

Mesh:

Substances:

Year:  2018        PMID: 29282854     DOI: 10.1002/anie.201708689

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  58 in total

Review 1.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

2.  Gold Nanocluster-Mediated Efficient Delivery of Cas9 Protein through pH-Induced Assembly-Disassembly for Inactivation of Virus Oncogenes.

Authors:  Enguo Ju; Tingting Li; Suzane Ramos da Silva; Shou-Jiang Gao
Journal:  ACS Appl Mater Interfaces       Date:  2019-09-10       Impact factor: 9.229

Review 3.  Melanoma treatment: from conventional to nanotechnology.

Authors:  Harshita Mishra; Pawan K Mishra; Adam Ekielski; Manu Jaggi; Zeenat Iqbal; Sushama Talegaonkar
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-09       Impact factor: 4.553

4.  Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.

Authors:  Xiaohong Chen; Yuxuan Chen; Huhu Xin; Tao Wan; Yuan Ping
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-15       Impact factor: 11.205

5.  Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel.

Authors:  Peng Guo; Jiang Yang; Jing Huang; Debra T Auguste; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

6.  Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing.

Authors:  Tuo Wei; Qiang Cheng; Lukas Farbiak; Daniel G Anderson; Robert Langer; Daniel J Siegwart
Journal:  ACS Nano       Date:  2020-07-22       Impact factor: 15.881

Review 7.  Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer.

Authors:  Yijing Liu; Pravin Bhattarai; Zhifei Dai; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2019-04-01       Impact factor: 54.564

8.  Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR-Cas9 plasmid.

Authors:  Ami Jo; Veronica M Ringel-Scaia; Dylan K McDaniel; Cassidy A Thomas; Rui Zhang; Judy S Riffle; Irving C Allen; Richey M Davis
Journal:  J Nanobiotechnology       Date:  2020-01-20       Impact factor: 10.435

Review 9.  CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.

Authors:  Garima Sharma; Ashish Ranjan Sharma; Manojit Bhattacharya; Sang-Soo Lee; Chiranjib Chakraborty
Journal:  Mol Ther       Date:  2020-09-20       Impact factor: 11.454

10.  Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes.

Authors:  Piyush K Jain; Justin H Lo; Santosh Rananaware; Marco Downing; Apekshya Panda; Michelle Tai; Srivatsan Raghavan; Heather E Fleming; Sangeeta N Bhatia
Journal:  Nanoscale       Date:  2019-10-31       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.